Vesna Glavicic

2.4k citations
11 papers · 50 indexed · h-index 5
Topics
Breast Cancer Treatment Studies (6 papers)Advanced Breast Cancer Therapies (4 papers)HER2/EGFR in Cancer Research (4 papers)

In The Last Decade

Vesna Glavicic

10 papers receiving 50 citations

Peers

Vesna Glavicic
Comparison fields: 5 of 21
  • Oncology 33
  • Cancer Research 21
  • Pulmonary and Respiratory Medicine 20
  • Molecular Biology 8
  • Biomaterials 6
Replace Sarra El-Abed with:
Sarra El-Abed Belgium
Saurin Chokshi United States
P. Dalivoust France
José Rodrigo Espinosa Fernández United States
Tienan Yi China
Laura Murillo Spain
Amy Stoll-D’Astice United States
A.A. Luczak Denmark
Samuel M. Niman United States
Annette Kolodzie United States
Vesna Glavicic relative to Sarra El-Abed Belgium Sarra El-Abed's profile →
Citations per field
00.5×10×13×
Sarra El-Abed · 1×
Citations per year

Countries citing papers authored by Vesna Glavicic

Since Specialization
Citations

This map shows the geographic impact of Vesna Glavicic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vesna Glavicic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vesna Glavicic more than expected).

Fields of papers citing papers by Vesna Glavicic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vesna Glavicic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vesna Glavicic. The network helps show where Vesna Glavicic may publish in the future.

Co-authorship network of co-authors of Vesna Glavicic

This figure shows the co-authorship network connecting the top 25 collaborators of Vesna Glavicic. A scholar is included among the top collaborators of Vesna Glavicic based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vesna Glavicic. Vesna Glavicic is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 2
2 0
3 6
4 3
5 2
6 4
7 17
8 1
9 6
10 5
11 4

About Vesna Glavicic

Vesna Glavicic is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 11 papers that have together received 50 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Advanced Breast Cancer Therapies (4 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Cancer Research (21 citations), Oncology (33 citations) and Pulmonary and Respiratory Medicine (20 citations). Vesna Glavicic has collaborated with scholars based in Denmark, United States and Norway. Frequent co-authors include Ann Knoop, Bent Ejlertsen, Dorte Nielsen, Maj‐Britt Jensen, Eva Balslev, Jeanette Dupont Jensen, F. Belmonte, Mads Nordahl Svendsen, Susanne Oksbjerg Dalton and Trine Allerslev Horsbøl. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment and Acta Oncologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026